Venture Capital

With a trillion-dollar wall of maturities and diverging asset performance, CREFC's upcoming conference will focus on high-yield and distressed opportunities.

Laurie Ann Goldman, the branding guru who built SPANX, is now CEO of Audien Hearing. Can she make affordable hearing aids a mainstream wellness product?

Global shocks are roiling fertilizer markets, creating a 'new normal' of price volatility. Can biological solutions offer farmers the stability they need?

Energy brand Wip partners with designer Bossi for a shocking leap into luxury fashion, blurring the lines between performance fuel and cultural identity.

With a new CRO from Zoom, LastPass aims to accelerate its B2B strategy, targeting the complex security challenges of the modern SaaS and AI-driven enterprise.

TruGolf accelerates its stock repurchase program, signaling faith in its future as it unveils new AI-powered tech in a booming indoor golf market.

A leading paint contractor earns top honors from Avetta, not just for paint, but for a deep commitment to teachers, veterans, and social responsibility.

As AI projects fail at alarming rates, this startup just raised $2.2M to fix the broken planning process that dooms them from the start.

Kincell Bio and RegCell partner to bring a groundbreaking, non-gene-edited Treg cell therapy for autoimmune diseases from the lab to clinical trials.

With a new CEO and stunning clinical data, BOOST Pharma advances a potential game-changer for children with the rare genetic disorder Osteogenesis Imperfecta.

Malta's national police force is rolling out the BolaWrap, a remote restraint device, aiming to reshape crisis response and reduce use of force.

Aardvark Therapeutics is expanding its Phase 3 trial for a novel Prader-Willi Syndrome drug to include children as young as seven, targeting a key unmet need.

With a fresh $28M in funding, Natilus is set to commercialize its hyper-efficient blended-wing aircraft, threatening the Boeing-Airbus duopoly.

Ahead of its first Climate Week, Mumbai's food innovators and activists gather to debate a sustainable future, proving the fight for the planet begins on our plates.

The drive-thru coffee giant is moving into your kitchen, taking on Starbucks and Nestlé with its new retail line. But can its 'Dutch Luv' succeed on shelves?

Amid major restructuring and a strategic asset sale, Standard BioTools' upcoming annual results will reveal its progress toward profitability in a tough market.

A new AI-native law firm uses tech to find dangerous products decades early, promising faster justice. But is it a revolution or a regulatory risk?

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

A key partnership between Silicon Catalyst and Chiplet Summit 2026 aims to accelerate the next wave of semiconductor innovators in a booming market.

The advisory giant's acquisition of a Boston-based specialist signals a strategic push into the high-stakes, high-growth world of life sciences and biotech.